title: Primary aldosteronism: challenges in diagnosis and management.
abstract: Primary aldosteronism (PA) is the main cause of endocrine hypertension, present in approximately 10% of hypertensive patients; about one-third is secondary to aldosterone-producing adenomas. Cardiovascular and renal morbidity are out of proportion to the degree of hypertension. Physicians have compelling rationale to correctly identify and treat PA. Physicians are challenged with patient selection for screening with the aldosterone/renin ratio (ARR), interpretation of ARR, and selecting a confirmatory test. Adrenal vein sampling is performed for subtype differentiation. The treatment depends on the disease subtype and results in control of hypertension and reversal of associated excess morbidity.
authors.affiliation: Trumbull, CT 06611, USA. Electronic address: sandijo.galati@gmail.com.
authors.forename: Sandi-Jo
authors.initials: SJ
authors.lastname: Galati
mesh_terms: D000306:Adrenal Cortex Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D000311:Adrenal Glands / Q000473:pathology*; D018246:Adrenocortical Adenoma / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D006801:Humans; D006929:Hyperaldosteronism / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D006965:Hyperplasia / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D006973:Hypertension / Q000209:etiology / Q000628:therapy
keywords: Aldosterone-producing adenoma; Bilateral adrenal hyperplasia; Endocrine hypertension; Primary aldosteronism